Total Payments
$4,505
2021 Payments
$721.06
Companies
28
Transactions
304
Medicare Patients
1,185
Medicare Billing
$66,121
Payment Breakdown by Category
Food & Beverage$4,453 (98.8%)
Education$52.18 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,453 | 301 | 98.8% |
| Education | $52.18 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,156 | 73 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $520.64 | 42 | $0 (2021) |
| GlaxoSmithKline, LLC. | $456.82 | 32 | $0 (2020) |
| PFIZER INC. | $309.16 | 32 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $199.65 | 14 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $184.29 | 6 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $133.69 | 9 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $129.93 | 10 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $122.64 | 8 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $121.61 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $721.06 | 28 | Novo Nordisk Inc ($165.52) |
| 2020 | $561.56 | 39 | Novo Nordisk Inc ($96.73) |
| 2019 | $904.19 | 64 | Novo Nordisk Inc ($253.31) |
| 2018 | $1,213 | 89 | Novo Nordisk Inc ($360.34) |
| 2017 | $1,105 | 84 | Novo Nordisk Inc ($279.91) |
All Payment Transactions
304 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/15/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/01/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: PRIMARY CARE | ||||||
| 06/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/23/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Diabetes | ||||||
| 06/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 06/16/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiovascular | ||||||
| 06/07/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Diabetes | ||||||
| 06/04/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Obesity | ||||||
| 05/26/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Diabetes | ||||||
| 05/19/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular | ||||||
| 05/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/29/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Gastroenterology | ||||||
| 04/29/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 04/28/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Diabetes | ||||||
| 04/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiovascular | ||||||
| 04/06/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/01/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: Neurology | ||||||
| 03/17/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/09/2021 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/05/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 13 | $3,614 | $1,315 |
| 2021 | 5 | 426 | 622 | $69,892 | $22,398 |
| 2020 | 11 | 748 | 1,242 | $135,483 | $42,408 |
Total Patients
1,185
Total Services
1,877
Medicare Billing
$66,121
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 13 | $3,614 | $1,315 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 144 | 208 | $48,626 | $14,592 | 30.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 113 | $18,129 | $6,166 | 34.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 13 | $1,235 | $830.72 | 67.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 163 | 250 | $1,750 | $723.80 | 41.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 19 | 38 | $152.00 | $85.50 | 56.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 173 | 291 | $67,803 | $20,340 | 30.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 176 | 284 | $44,872 | $10,939 | 24.4% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 13 | 13 | $3,328 | $2,873 | 86.3% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 11 | 12 | $5,940 | $2,209 | 37.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 198 | 442 | $3,094 | $1,308 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $2,739 | $1,291 | 47.1% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 61 | 65 | $1,521 | $1,259 | 82.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 62 | 66 | $3,102 | $1,104 | 35.6% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 11 | 24 | $2,088 | $723.30 | 34.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 20 | 20 | $940.00 | $331.46 | 35.3% |
| 81003 | Automated urinalysis test | Office | 2020 | 12 | 14 | $56.00 | $31.15 | 55.6% |
About Dr. Moe Mya, M.D
Dr. Moe Mya, M.D is a Internal Medicine healthcare provider based in Abingdon, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104930502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Moe Mya, M.D has received a total of $4,505 in payments from pharmaceutical and medical device companies, with $721.06 received in 2021. These payments were reported across 304 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,453).
As a Medicare-enrolled provider, Mya has provided services to 1,185 Medicare beneficiaries, totaling 1,877 services with total Medicare billing of $66,121. Data is available for 3 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Abingdon, VA
- Active Since 08/19/2006
- Last Updated 02/21/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104930502
Products in Payments
- XARELTO (Drug) $488.71
- Ozempic (Drug) $456.48
- Saxenda (Drug) $327.75
- XIFAXAN (Drug) $242.12
- ANORO (Drug) $209.16
- Victoza (Drug) $204.25
- CHANTIX (Drug) $190.95
- FARXIGA (Drug) $172.59
- ENTRESTO (Drug) $133.69
- BREO (Drug) $123.11
- Vascepa (Drug) $121.58
- JANUVIA (Drug) $118.89
- LUPKYNIS (Drug) $115.00
- TRULICITY (Drug) $103.00
- ELIQUIS (Drug) $81.07
- Amitiza (Drug) $74.98
- Tresiba (Drug) $72.87
- SOLIQUA (Drug) $70.32
- TRELEGY ELLIPTA (Drug) $69.20
- Horizant (Drug) $63.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Abingdon
Emory Robinette, M.d, M.D
Internal Medicine — Payments: $66,893
Internal Medicine $66,893
Clinton Sutherland, Md, MD
Internal Medicine — Payments: $30,337
Internal Medicine $30,337
Haytham Adada, Md, MD
Internal Medicine — Payments: $10,638
Internal Medicine $10,638
Robert Jones, M.d, M.D
Internal Medicine — Payments: $10,385
Internal Medicine $10,385
Dr. Jonathan Swank, Md, MD
Internal Medicine — Payments: $6,901
Internal Medicine $6,901
Dr. William Baker, Md, MD
Internal Medicine — Payments: $4,876
Internal Medicine $4,876